Security key
152309100
Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (CNTA)
CUSIP: 152309100
Q1 2023 13F Holders as of 31 Mar 2023
- Security type / class
- Equity / Ordinary Shares, nominal value GBP 0.002 per share
- Total 13F shares
- 66,895,058
- Total 13F value
- $257,540,618
- Share change
- +2,959,490
- SEC-reported price per share
- $3.85
- Number of holders
- 42
- Value change
- +$13,125,714
- Number of buys
- 16
- Number of sells
- 14
- Shares outstanding
- 154,150,943
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q1 2023
Institutions
42
Top holders
10
CNTA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2023
Previous quarter: Q4 2022
Centessa Pharmaceuticals plc SEC filings
Centessa Pharmaceuticals plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 152309100
Recent filing periods:
Ownership snapshot
Top reported holders of CNTA - Centessa Pharmaceuticals plc - Ordinary Shares, nominal value GBP 0.002 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Medicxi Ventures Manageme...
Disclosed value leader
Medicxi Ventures Manageme...
Comparable rows
15/15
Latest evidence
31 Dec 2022
13F
3/4/5
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
Medicxi Ventures Management (Jersey) Ltd leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Medicxi Ventures Management (Jers...
13%
GENERAL ATLANTIC, L.P.
6.3%
BVF INC/IL
4.5%
EcoR1 Capital, LLC
3.4%
Vida Ventures Advisors, LLC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd |
13F
3/4/5
Company · 10%+ Owner
|
13%
|
$61,885,786
19,963,157 shares
|
— | 31 Dec 2022 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
6.3%
|
$30,013,636
9,681,818 shares
|
— | 31 Dec 2022 |
| BVF INC/IL |
13F
Company
|
4.5%
|
$21,372,470
6,894,345 shares
|
— | 31 Dec 2022 |
| EcoR1 Capital, LLC |
13F
Company
|
3.4%
|
$16,220,065
5,232,279 shares
|
— | 31 Dec 2022 |
| Vida Ventures Advisors, LLC |
13F
Company
|
2.6%
|
$12,188,636
3,931,818 shares
|
— | 31 Dec 2022 |
| OUP Management Co., LLC |
13F
Company
|
1.9%
|
$9,106,607
2,937,615 shares
|
— | 31 Dec 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
66,895,058
Rows available
42
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
41
Q1 2023 holders
42
Holder diff
1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 value | Q1 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend